In vitro studies and WT1 peptide vaccine trials of patients with leukemias and various types of solid tumors have demonstrated that cytotoxic activity of WT1-specific CD8+ T cells can be induced by these stimuli (13–15). This evidence concerns the gene CD8A and leukemia.